Iradimed (IRMD) Cash from Investing Activities (2013 - 2026)

Iradimed (IRMD) has 14 years of Cash from Investing Activities data on file, last reported at -$469000.0 in Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 88.03% year-over-year to -$469000.0 in Q1 2026; TTM through Mar 2026 was -$5.0 million, a 59.42% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 4.49% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$469000.0, down from -$416407.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for IRMD reached as high as $77561.0 in Q2 2022 and fell as low as -$6.6 million in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$1.6 million across 5 years, with a median of -$556188.0 in 2022.
• Across the five-year window, Cash from Investing Activities slumped 1443.94% in 2023 and jumped 92.7% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$471676.0 in 2022, then sank by 34.16% to -$632816.0 in 2023, then slumped by 383.07% to -$3.1 million in 2024, then surged by 86.38% to -$416407.0 in 2025, then fell by 12.63% to -$469000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$469000.0 in Q1 2026, -$416407.0 in Q4 2025, and -$1.3 million in Q3 2025.